Enzocast DS Tablet is a combination pharmaceutical formulation containing Bromelain (180 mg), Trypsin (96 mg), Rutoside (200 mg), and Papain (120 mg), designed to provide potent anti-inflammatory, proteolytic, and antioxidant effects. Bromelain and Papain are proteolytic enzymes that facilitate the breakdown of proteins, thereby aiding in the reduction of edema, inflammation, and promoting wound healing. Trypsin, another proteolytic enzyme, enhances the anti-inflammatory response by modulating the immune system and accelerating tissue repair. Rutoside, a bioflavonoid, exhibits strong antioxidant properties and strengthens capillary walls, reducing vascular permeability and preventing microvascular bleeding. The synergistic action of these components makes Enzocast DS effective in managing acute and chronic inflammatory conditions, including post-traumatic swelling, postoperative edema, and musculoskeletal disorders such as sprains and strains. Additionally, it supports faster recovery by enhancing fibrinolytic activity and reducing pain and inflammation. Enzocast DS is typically prescribed as an adjunct therapy alongside conventional treatment modalities to improve patient outcomes. It should be used under medical supervision, considering contraindications such as hypersensitivity to any component and bleeding disorders. Adherence to prescribed dosage and duration is essential to maximize therapeutic benefits while minimizing potential adverse effects.